On 7 November 2025, the Indian stock market experienced a third consecutive session of marginal declines, with the BSE Sensex closing down by 94 points (0.1%) and NSE Nifty down by 17 points (0.1%), reflecting cautious investor sentiment amid persistent foreign outflows.
Despite opening lower and continuing downward momentum early in the day, markets managed some recovery towards the close but still ended slightly negative, indicating mixed retail sentiment with profit booking prevailing.
Sectoral movements were mixed; while media and telecommunication sectors saw selling pressure, metal and auto sectors attracted buying interest, suggesting selective investor confidence within the market.
The BSE MidCap index rose by 0.2% while the SmallCap index ended marginally lower by 0.1%, pointing to a modest divergence in mid and small-cap performances.
Macroeconomic factors such as a stable yet slightly weakened rupee at 88.7 per US dollar and rising gold prices buoyed by uncertainty also influenced market dynamics on the day.
Key Indices
NIFTY 50
25,492
-0.07%
SENSEX
83,216.28
-0.11%
Momentum Snapshot
Index
Price
1D
1M
1Y
Sensex
83,216.28
-0.11%
1.76%
4.69%
Nifty Midcap 100
59,843
0.63%
2.67%
4.79%
Nifty Next 50
69,366
0.10%
1.01%
-1.80%
Nifty 50
25,492
-0.07%
1.53%
5.34%
Nifty Smallcap 250
17,020
-0.24%
-0.17%
-4.99%
Sector Highlights
Metal
+1.41%
The Metal sector rose 1.41% driven by positive momentum in steel companies such as Steel Ltd Mahind & Mahra Ltd, which gained over 2%. This uplift reflects strong quarterly earnings results and improved demand expectations for steel products, supporting the sector despite broader market weakness.
PSU Bank
+0.87%
PSU Bank stocks gained 0.87% supported by a rebound in financials amid healthy Q2 results and relief from concerns over asset quality. Specifically, State Bank of India showed a modest rise, reflecting confidence in stable credit growth and improved collection efficiency.
Auto
+0.57%
The Auto sector increased 0.57%, buoyed by firm Q2 earnings from major players like Bajaj Auto and positive market sentiment on steady vehicle demand. This intraday strength countered overall market weakness and was supported by incremental improvement in domestic demand and export prospects.
FMCG
-0.49%
FMCG declined 0.49% primarily due to profit booking after recent gains and cautious investor stance ahead of quarterly results. Key stocks like Tata Consumer Products fell around 2%, reflecting concerns about margin pressure from rising input costs amid muted volume growth in core consumption segments.
IT
-0.62%
The IT sector declined 0.62% pressured by weak global cues and Wall Street losses, especially in technology stocks amid fears of AI valuations being overheated. This global tech sentiment impacted Indian IT stocks, contributing to the sector's underperformance despite upcoming earnings releases.
Sector Scoreboard
Sector
1D
1W
1Y
3Y
Metal
+1.41%
-4.17%
+6.48%
+62.58%
PSU Bank
+0.87%
+2.75%
+18.59%
+134.40%
Auto
+0.57%
-0.76%
+10.31%
+100.63%
FMCG
-0.49%
-1.12%
-5.18%
+25.17%
IT
-0.62%
-1.58%
-15.94%
+23.16%
Movers of the Day
Top Nifty Gainers
Shriram Finance
3.01%
No significant updates available for this stock.
Adani Enterpris
2.38%
No significant updates available for this stock.
Bajaj Finance
2.37%
No significant updates available for this stock.
Tata Steel
2.31%
Tata Steel rose amid positive long-term sentiment for the steel sector, particularly as the industry's shift towards greener electric arc furnaces is expected to benefit related businesses.
M&M
1.98%
M&M gained after the company announced its strategic plan to exit its stake in RBL Bank through a block deal, which is expected to yield a substantial 64% return on its investment.
Top Nifty Losers
Bharti Airtel
-4.47%
Bharti Airtel fell sharply due to significant selling pressure from reports of its promoter Singtel planning to sell a 0.8% stake through a large block deal.
TATA Cons. Prod
-1.95%
No significant updates available for this stock.
Interglobe Avi
-1.92%
Interglobe Avi declined as reports indicated that its promoters were among the significant sellers of their holdings in the market, raising concerns about insider confidence.
Tech Mahindra
-1.90%
No significant updates available for this stock.
Apollo Hospital
-1.80%
No significant updates available for this stock.
Stock Spotlight Of The Day
Alembic Pharmaceuticals
Market Cap
18,112 Cr
Current Price
₹922
Stock P/E
28.6
Dividend Yield
1.19%
ROCE
13.0%
ROE
11.4%
Shareholding Changes (Impact Factors)
FIIs
QoQ
0.08%
YoY
0.1%
Stable foreign holding
DIIs
QoQ
-0.16%
YoY
0.25%
Stable domestic holding
Promoters
QoQ
0.06%
YoY
0.13%
Slight confidence boost
Quarterly Summary (Absolute)
Sales
QoQ
Solid pickup
11.63%
YoY
Solid pickup
15.9%
Expenses
QoQ
Costs rising
11.47%
YoY
Costs rising
13.13%
Operating Profit
QoQ
Healthy pickup
12.46%
YoY
Strong profit
32.22%
Net Profit
QoQ
Healthy growth
19.48%
YoY
Strong earnings
20.26%
Profit & Loss (Compounded)
Sales Growth
10 Years
12%
5 Years
8%
3 Years
8%
TTM
11%
Profit Growth
10 Years
7%
5 Years
-8%
3 Years
3%
TTM
0%
Stock Price CAGR
10 Years
3%
5 Years
-1%
3 Years
14%
1 Year
-15%
Return on Equity
10 Years
18%
5 Years
13%
3 Years
11%
Last Year
11%
Fundamentals Corner
The company is showing strong signs of a turnaround with accelerating sales and a sharp jump in recent quarterly profits, breaking from a long-term trend of declining profitability and mediocre returns on equity.
However, the stock's high valuation (P/E of 28.6) already seems to price in this recovery, so investors should watch for sustained earnings momentum to justify the premium.
News TidBits
Alembic Pharmaceuticals received a significant approval from the US Food and Drug Administration (FDA) for its Dasatinib tablets.
These tablets are a generic version of a high-value drug used in the treatment of specific types of leukemia in adults.
This approval is a major boost for the company's valuable oncology portfolio and strengthens its presence in the highly competitive US generics market.
The development aligns with the Indian government's Production-Linked Incentive (PLI) scheme, which encourages domestic pharma companies to expand their global export footprint.
This milestone is expected to positively impact the company's revenue and margins, making it a key stock to watch in the pharmaceutical sector.
Stacks on Stacks: Tip Time 🤑
Don't mistake a bull market for genius; the real test of an investor is maintaining discipline and sticking to a sound process during market corrections, not just participating in a rally.
Inside The Fund
DSP Large Cap Fund
Fund Size: ₹ 6620.66 Cr
NAV: ₹ 523.186 (as on 06th November, 2025)
1 Year
3.59%
Category: 4.09%
2 Year
20.49%
Category: 17.95%
3 Year
17.94%
Category: 15.50%
5 Year
18.29%
Category: 18.21%
10 Year
12.94%
Category: 13.83%
Top 10 Holdings
Stock
Holding %
1M Change
HDFC Bank Ltd.
8.65%
-0.31%
ICICI Bank Ltd.
7.18%
-0.52%
ITC Limited
5.90%
0.70%
Mahindra & Mahindra Ltd.
5.72%
0.20%
Infosys Ltd.
5.48%
0.72%
Axis Bank Ltd.
5.07%
0.22%
Kotak Mahindra Bank Ltd.
5.06%
0.08%
National Thermal Power Corporation Ltd.
4.93%
0.03%
Cipla Ltd.
4.61%
-0.44%
SBI Life Insurance Co Ltd.
4.11%
-0.18%
The Common Ground
Shows the commonly added & removed stocks by mutual funds last month
Top Added (2)
Piramal Finance Ltd.
2 funds
Kotak Multicap Fund - Direct Plan - Growth
0.91%
Mahindra Manulife Multi Cap Fund - Direct Plan - Growth
1.40%
Mahindra & Mahindra Ltd.
2 funds
ICICI Prudential Multicap Fund - Direct Plan - Growth
0.42%
Mahindra Manulife Multi Cap Fund - Direct Plan - Growth
1.50%
Top Removed (5)
Avenue Supermarts Ltd.
2 funds
Nippon India Multicap Fund - Direct Plan - Growth
-0.07%
Mirae Asset Multicap Fund - Direct Plan - Growth
-0.26%
Piramal Enterprises Ltd.
2 funds
Kotak Multicap Fund - Direct Plan - Growth
-0.96%
Mahindra Manulife Multi Cap Fund - Direct Plan - Growth
-1.41%
Gujarat State Petronet Ltd.
2 funds
Kotak Multicap Fund - Direct Plan - Growth
-0.14%
ICICI Prudential Multicap Fund - Direct Plan - Growth
-0.39%
Federal Bank Ltd.
2 funds
ICICI Prudential Multicap Fund - Direct Plan - Growth
-0.87%
Mahindra Manulife Multi Cap Fund - Direct Plan - Growth
-0.10%
Container Corporation Of India Ltd.
2 funds
ICICI Prudential Multicap Fund - Direct Plan - Growth
-0.67%
Quant Multi Cap Fund - Direct Plan - Growth
-2.50%
Top News Developments
M&M's Strategic Exit: 64% Gain from RBL Bank Stake Sale
Mahindra & Mahindra's decision to sell its stake in RBL Bank signals a strategic shift to concentrate on its core automotive and farm equipment businesses.
The profitable exit, realizing a 64% return, sends a strong bullish signal about the improved health and asset quality of the Indian banking sector.
This move could encourage other diversified corporations to rationalize their non-core investments, potentially unlocking value and increasing market liquidity.
For investors, this highlights the value of management focusing on core competencies and could make M&M's stock more attractive due to a cleaner business profile.
Pharma and Consumer Sectors Shine with Strong Q2 Earnings
A robust earnings season is underway, with several pharmaceutical companies like Lupin and Divi's Laboratories reporting multi-fold profit growth driven by strong sales and margin expansion.
The consumer discretionary space also showed strength, with jewellery retailers like Kalyan Jewellers nearly doubling their profit and beauty platform Nykaa reporting a 243% surge in net profit.
This trend suggests a revival in both domestic consumption and export-oriented sectors, providing positive cues for investors.
Retail investors should look for companies demonstrating not just revenue growth but also margin improvement, as this indicates strong pricing power and operational efficiency.
Alembic Pharma Secures Key US FDA Nod for Cancer Drug
The US FDA approval for Dasatinib tablets opens up a large and lucrative market for Alembic Pharma in the high-value oncology segment.
This success underscores the growing capability of Indian pharmaceutical firms to compete in the complex generics space globally.
The approval aligns with the government's PLI scheme, which supports domestic manufacturing for export, potentially leading to better incentives for the sector.
For investors, this is a significant de-risking event for Alembic Pharma and enhances its long-term revenue visibility from the US market.
Telecom Sector Jolted by Promoter Selling and Block Deals
Bharti Airtel's stock faced heavy selling pressure after reports that its promoter Singtel is planning to sell a stake worth nearly ₹10,300 crore.
This adds to broader concerns as promoters of other major firms like InterGlobe Aviation have also been reported as significant sellers.
Such large-scale selling by promoters can signal a potential peak in valuation or a need to raise capital, often leading to short-term price corrections.
Retail investors should monitor such block deals closely as they can create significant stock price volatility and signal shifts in long-term promoter confidence.
FII / DII Snapshot
Yesterday
FII Net: ₹-3263.21 cr
DII Net: ₹5283.91 cr
October 2025
FII Net: ₹-2346.89 cr
DII Net: ₹52794.02 cr
Daily Flows
Date
FII Net
DII Net
06-Nov-2025
₹-3263.21 cr
₹5283.91 cr
04-Nov-2025
₹-1067.01 cr
₹1202.90 cr
03-Nov-2025
₹-1883.78 cr
₹3516.36 cr
Monthly Flows
Month
FII Net
DII Net
October 2025
₹-2346.89 cr
₹52794.02 cr
September 2025
₹-35301.36 cr
₹65343.59 cr
August 2025
₹-46902.92 cr
₹94828.55 cr
July 2025
₹-47666.68 cr
₹60939.16 cr
June 2025
₹7488.98 cr
₹72673.91 cr
May 2025
₹11773.25 cr
₹67642.34 cr
• Foreign Institutional Investors (FIIs) continued their selling streak, offloading a net of ₹3,263.21 crores, contributing to the market's cautious sentiment and profit-taking pressure.
• This outflow aligns with a broader monthly trend where FIIs have been net sellers, indicating a strategic reduction in exposure to Indian equities amid global uncertainties.
• Conversely, Domestic Institutional Investors (DIIs) acted as a strong countervailing force, with robust net purchases of ₹5,283.91 crores, providing crucial liquidity and absorbing the selling pressure to support the market at current levels.
IPO Watchlist
Ongoing IPOs
The IPO for Groww T, which saw strong demand with a subscription of 17.58 times, is closing today, though its grey market premium has reportedly slipped, signaling a need for investor caution.
Pine Labs' public issue remains open for subscription but has seen muted interest so far with only 0.13 times subscription.
Despite the slow start, analysts have recommended the Pine Labs IPO for long-term investment, suggesting potential value for patient investors.
Pine Labs
3899.91
Date: 7 Nov - 11 Nov
List: 14 Nov
Subscription: 0.13x
GMP: 2.26%
Groww T
6632.30
Date: 4 Nov - 7 Nov
List: 12 Nov
Subscription: 17.58x
GMP: 4.75%
Upcoming IPOs
The IPO market is set to see significant activity with several large issues opening next week, including Tenneco Clean Air, PhysicsWallah, and Emmvee Photovoltaic.
Auto-component manufacturer Tenneco Clean Air India will launch its large ₹3,600 crore IPO on November 12, which is entirely an offer for sale by existing shareholders.
Edtech firm PhysicsWallah, which plans to raise ₹3,480 crore, is also launching its IPO while simultaneously planning a major offline expansion by raising funds to open 200 new centres.
Tenneco Clean Air
3600.00
Date:12 Nov - 14 Nov
List:19 Nov
Subscription: -
GMP: 20.91%
PhysicsWallah
3480.00
Date:11 Nov - 13 Nov
List:18 Nov
Subscription: -
GMP: 4.59%
Emmvee Photovoltaic
2900.00
Date:11 Nov - 13 Nov
List:18 Nov
Subscription: -
GMP: 9.22%
Cha-Ching Cheatsheet 💵
Conviction is not about being stubborn but about having done enough research to justify your position; the market will test your patience, but only a well-researched thesis gives you the right to be patient.
Global markets opened on a cautious note on 7 November 2025, influenced by a volatile Wall Street session with concerns over inflated AI sector valuations and signs of a softening US labor market dampening investor sentiment worldwide.
Key Asian indices like Japan's Nikkei 225 and Topix, Australia's S&P/ASX 200, and Hong Kong's Hang Seng declined between 0.4% to 1.9%, reflecting regional risk aversion that impacted Indian equities.
S&P 500 futures remained largely unchanged, indicating a wait-and-watch mode among global investors, which contributed to subdued momentum in emerging markets including India.
Worries regarding ongoing US government shutdown continued to create uncertainty over the availability and reliability of economic data, adding to the cautious global market mood on 7 November 2025.
Currency pressures were evident with Asian currencies weakening alongside the Indian rupee, as traders monitored potential central bank interventions and geo-economic risks influencing cross-border capital flows.
Emerging Opportunities
The auto and metal sectors emerged as promising areas for investment on 7 November 2025, backed by sectoral buying interest amid broader market caution, signaling medium-term growth potential.
Financial stocks led a strong recovery later in the day, particularly PSU banks, highlighting a contrarian opportunity for investors looking to capitalize on value plays amid transient foreign outflows.
Policy progress and optimism surrounding India–U.S. trade talks provide a supportive backdrop for export-oriented sectors and companies expected to benefit from enhanced bilateral cooperation.
Stability in the rupee despite global currency pressures suggests potential in sectors sensitive to currency fluctuations such as IT services and pharmaceuticals, where a stable currency aids profitability.
Emerging tech-related valuations had faced recent corrections, presenting selective contrarian opportunities for long-term investors amid the volatility in global AI and tech stocks influencing Indian counterparts.
Policy & Regulations
Market regulator SEBI is actively reviewing key market frameworks, including regulations for short-selling and securities lending and borrowing, which could impact trading strategies and market liquidity.
SEBI is also intensifying its crackdown on unregulated financial influencers operating on social media platforms to protect retail investors from misinformation and fraudulent advice.
In a positive development for market sentiment, the Finance Minister's assurance of a thoughtful and calibrated approach to any new Futures & Options (F&O) regulations has provided relief to capital market-linked stocks like BSE and CDSL.
Crypto Buzz
Name
Price
Market Cap
24h Change
ATH Change
Bitcoin (BTC)
$99889
$1.99T
-3.09%
-20.57%
Ethereum (ETH)
$3230.12
$390.50B
-4.95%
-34.27%
Tether (USDT)
$0.999565
$183.37B
-0.04%
-24.45%
XRP (XRP)
$2.17
$130.54B
-5.32%
-40.33%
BNB (BNB)
$938.95
$129.56B
-1.78%
-31.21%
The cryptocurrency market experienced a broad-based decline over the last 24 hours, with major tokens posting significant losses, reflecting cautious investor sentiment.
Bitcoin fell by over 3% to trade around $99,889, while Ethereum saw a sharper drop of nearly 5%, indicating weakness among the market leaders.
Other major altcoins like XRP and BNB also recorded substantial losses of over 5% and 1.7% respectively, pulling down the overall market capitalization.
Inside The Fund
